Posts
April 22 2025
Aptevo Therapeutics Inc. announced the closing of its Registered Direct Offering in the amount of $2,000,000. EG&S acted as counsel to the Placement Agent.
April 21 2025
Client Alert: U.S. Citizenship and Immigration Services Issues New Form I-9 For Employment Eligibility Verification
U.S. Citizenship and Immigration Services (USCIS) issued a new version of its Form I-9 on January 20, 2025, which has a May 31, 2027 expiration date. Although previous versions of the Form I-9 remain valid until their stated expiration dates, employers should immediately begin using this new version for all new hires, re-hires, and re-verifications.
Click here to read the alert.
April 21 2025
NioCorp Developments Ltd. announced the closing of its Underwritten Public Offering in the amount of $20,000,000. EG&S acted as counsel to the Underwriter.
April 15 2025
Can-Fite Biopharma Ltd. announced the closing of its Registered Direct Offering in the amount of $3,000,000. EG&S acted as counsel to the Placement Agent.
April 14 2025
Venus Concept Inc. announced the closing of its Registered Direct Offering in the amount of $1,500,000. EG&S acted as counsel to the Placement Agent.
April 10 2025
Immunic, Inc. announced the closing of its Registered Direct Offering in the amount of $5,100,000. EG&S acted as counsel to the Placement Agent.
April 10 2025
Venus Concept Inc. announced the closing of its Registered Direct Offering in the amount of $1,100,000. EG&S acted as counsel to the Placement Agent.
April 07 2025
NeuroOne Medical Technologies Corporation announced the closing of its Underwritten Public Offering in the amount of $8,000,000. EG&S acted as counsel to the Underwriter.